ImmunArray's Series B Round

ImmunArray raised a round of funding on July 13, 2016. Investors include Exigent Capital.

ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and…

Articles about ImmunArray's Series B Round: